Network Insights Methodology Whitepaper Get Access

Merck

ORG Health Care / Pharmaceuticals Momentum 20.9ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$59.3B market cap (Rahway, NJ) manufactures oncology, vaccines, and antiviral drugs. Cutting Zepatier hepatitis C drug pricing sharply to defend market share against generic and biosimilar competition.

Price reduction strategy on Zepatier (sofosbuvir/velpatasvir) hepatitis C treatment to improve market access and competitiveness in antiviral segment.
-0.32
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
20.9
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
10
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
Merck is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
Novartis China Eli Lilly PlocamiumAI AstraZeneca FDA Washington India New Jersey European Union Europe HHS Robert F. Kennedy Jr. Paris Reuters
Watch This Entity
PSI Intelligence
30-Day Trend
2026-06-17 2026-07-17 10 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.235
Narrative Drift
0.000
Spectral Shift
595.316
Sentiment-Momentum Divergence
0.000
Source Concentration
0.906
Signal
Merck is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #23 of 72 in Health Care — in line with sector peers. PSI up 0.25 from yesterday (-0.57 -> -0.32).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
23 of 72
Sector Rank
+0.48
Peer Z-Score
69%
Sector Percentile
Network Analysis
10 Degree Centrality
Ego Network (top connections)
Novartis (weight 121.0)China (weight 18.0)Eli Lilly (weight 13.0)PlocamiumAI (weight 11.0)AstraZeneca (weight 9.0)FDA (weight 9.0)Washington (weight 6.0)India (weight 4.0) NovartisChinaEli LillyPlocamiumAIAstraZenecaFDAWashingtonIndia Merck (degree 10) Merck
Centrality History
2026-06-17 2026-07-17 10 0 Degree Mentions
EntityWeight StatusFirst Seen
Novartis 121 NEW
China 18 STRENGTHENED
Eli Lilly 13 NEW
PlocamiumAI 11 NEW
AstraZeneca 9 NEW
FDA 9 STABLE
Washington 6 STABLE
India 4 STABLE
New Jersey 4 NEW
European Union 3 STABLE
Europe 2 NEW
HHS 2 STABLE
Robert F. Kennedy Jr. 2 NEW
Paris 2 NEW
Reuters 2 STABLE
Bloomberg 2 STABLE
Dr 1 NEW
NASA 1 STABLE
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-07-17 ← Intelligence Network